Alexis Kudyba
Senior Director, Commercialization Counsel at TG Therapeutics, Inc. - New York, NY, US
Alexis Kudyba's Colleagues at TG Therapeutics, Inc.
Alexis Kudyba's Contact Details
HQ
(212) 554-4484
(212) 554-4484
Location
New York City Metropolitan Area
New York City Metropolitan Area
Company
TG Therapeutics, Inc.
TG Therapeutics, Inc.
Alexis Kudyba's Company Details
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).
Frequently Asked Questions about Alexis Kudyba
Alexis Kudyba currently works for TG Therapeutics, Inc..
Alexis Kudyba's role at TG Therapeutics, Inc. is Senior Director, Commercialization Counsel.
Alexis Kudyba's email address is ***@tgtxinc.com. To view Alexis Kudyba's full email address, please signup to ConnectPlex.
Alexis Kudyba works in the BioTech/Drugs industry.
Alexis Kudyba's colleagues at TG Therapeutics, Inc. are Sally Styring, Brett Smith, Benjamin Yee, Gregory Yen, John Ventrello, Nate Carsto, Amanda Karlavage and others.
Alexis Kudyba's phone number is (212) 554-4484